If you have looked into GLP-1 options, you have probably seen two very different things sold under names that sound almost the same: Wegovy and compounded semaglutide. They are not the same thing, they are not interchangeable, and the difference matters — legally, clinically, and for what anyone is allowed to promise you.
Here is the honest version, without the marketing.
Wegovy is an FDA-approved medication
Wegovy is a brand-name, manufacturer-made medication that the FDA has reviewed and approved for chronic weight management, alongside a reduced-calorie diet and increased physical activity. "FDA-approved" means it went through the agency's process for safety, effectiveness, and manufacturing quality before it reached the market, and it carries an approved label describing exactly how it is meant to be used.
Because it is FDA-approved, there is published clinical-trial evidence behind it. In its STEP 1 trial, participants taking the highest studied dose lost, on average, 14.9% of their body weight over 68 weeks — as an adjunct to a reduced-calorie diet and more physical activity, not as a stand-alone result and not a prediction of what any individual will experience. Results vary, not everyone qualifies, and no outcome is guaranteed.
Compounded semaglutide is a different category entirely
A compounded medication is prepared by a state-licensed pharmacy for an individual patient, based on a licensed prescriber's order, to meet a documented clinical need. It is not FDA-approved, it is not a generic, and it is not a copy of Wegovy. Compounded preparations do not go through the FDA approval process, so there is no approved label and no outcome claim attached to them.
That is why a responsible program will never advertise a weight-loss figure for a compounded preparation. At OS Reboot, compounded semaglutide is offered only as part of physician-directed metabolic care — a licensed physician in the independent medical network decides whether a compounded preparation is medically appropriate for a specific person. It is framed around metabolic support, not a promised number on the scale, because that is the only accurate and compliant way to describe it.
So why does compounding exist at all?
Compounding has a real, long-standing role in medicine. A pharmacy may prepare a medication in a form, strength, or ingredient combination that a commercial product does not offer — a different route of administration, the removal of an ingredient someone reacts to, or a response to a documented supply issue. The prescription is still a prescription, and a clinician still has to decide it is appropriate.
What compounding is not is a shortcut around FDA approval, or a way to get "the same thing for less." Anyone telling you a compounded preparation is identical to an approved drug is skating past the rules — the FDA has been explicit that compounded medications are not FDA-approved and are not copies of approved drugs.
How to actually think about the choice
The decision is not one you make from a website, and it is not one we make for you. A few honest guideposts:
- Start with a licensed clinician. Whether an FDA-approved medication, a compounded preparation, or neither is right for you depends on your history, your labs, and your goals. That evaluation is the whole point.
- Match the claim to the category. Weight-management evidence belongs to the FDA-approved products and their own trials. Compounded care is described in terms of metabolic support, because that is what the evidence base allows.
- Ask how it is overseen. Who is the prescribing physician? Which pharmacy prepares it? Is there follow-up? Oversight is the difference between a medical program and a storefront.
The bottom line
Wegovy and compounded semaglutide are not two versions of one product. One is an FDA-approved weight-management medication with published trial data; the other is a compounded preparation used, when a physician judges it appropriate, as part of metabolic care — with no outcome claims attached. Knowing which is which is the first step to making a decision you can actually trust.
If you want a licensed physician to tell you which path — if any — fits your situation, that is exactly what a telehealth review is for. You can read more about compounded semaglutide and Wegovy, and a physician decides what is appropriate only after reviewing your information.
This article is educational information about GLP-1 medications, not medical advice, a diagnosis, or a prescription. OS Reboot does not practice medicine or operate a pharmacy; every medical decision is made by a licensed clinician based on your individual evaluation.